Table 1 Comparison of demographic and clinical data among studied groups
Variables | Group 1 (25) | Group 2 (22) | Group 3 (26) | Group 4 (20) | P value |
|---|---|---|---|---|---|
Age (years) | 0.35 | ||||
X ± SD | 51.72 ± 5.8 | 49.13 ± 9.11 | 49.84 ± 3.7 | 51.75 ± 4.15 | |
Gender | |||||
Male | 13 (52%) | 10 (45.5%) | 16 (61.5%) | 11 (55%) | 0.73 |
Female | 12 (48%) | 12 (54.5%) | 10 (38.5%) | 9 (45%) | |
Duration (years) | 0.001* | ||||
Median (range) | 3 (1–10) | 3 (1–11) | 4 (1–24) | 10 (2–24) | |
Smoking | 1 (4%) | 1 (4.5%) | 5 (19.2%) | 3 (15%) | 0.22 |
BMI category | |||||
18–25 | 1 (4%) | ||||
>25–30 | 5 (20%) | 7 (31.8%) | 6 (23.1%) | 5 (25%) | 0.74 |
>30 | 19 (76%) | 15 (68.2%) | 20 (76.9%) | 15 (75%) | |
SBP (mmHg) | 0.41 | ||||
X ± SD | 138.8 ± 26.42 | 149.09 ± 26.48 | 139.62 ± 26.34 | 146.5 ± 17.45 | |
Range | 130 (110–200) | 152.5 (110–200) | 127.5 (110–180) | 150 (120–170) | |
DBP (mmHg) | 0.13 | ||||
X ± SD | 86.8 ± 10.09 | 91.13 ± 7.54 | 87.3 ± 8.74 | 91.75 ± 8.15 | |
Range | 85 (70–120) | 95 (80–100) | 85 (75–100) | 95 (80–100) | |
HTN | 5 (20%) | 13 (59.1%) | 11 (42.3%) | 14 (70%) | 0.004 |
IHD | 2 (8%) | 4 (18.2%) | 2 (7.7%) | 3 (15%) | 0.61 |
HCT | 2 (8%) | 4 (18.2%) | 6 (23.1%) | 5 (25%) | 0.43 |
Neuropathy | 0 | 1 (4.5%) | 6 (23.1%) | 6 (30%) | 0.008 |
CRP (mg/l) X ± SD | 9.6 ± 3 | 13.41 ± 4.59 | 14.35 ± 1.54 | 19.8 ± 2.59 | 0.0001◊# |